ANGO
AngioDynamics, Inc.NASDAQHealthcare$10.31-4.56%ClosedMarket Cap: $425.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.36
P/S
1.29
EV/EBITDA
-54.00
DCF Value
$2.68
FCF Yield
0.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.5%
Operating Margin
-7.2%
Net Margin
-10.0%
ROE
-17.6%
ROA
-12.0%
ROIC
-11.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $78.4M | 52.9% | $-3.8M | $-8.1M | $-0.19 | — |
| Q2 2026 | $79.4M | 53.1% | $-2.5M | $-6.3M | $-0.15 | — |
| Q1 2026 | $75.7M | 55.3% | $-10.7M | $-10.9M | $-0.26 | — |
| Q4 2025 | $80.2M | 52.7% | $-5.8M | $-6.0M | $-0.15 | — |
| FY 2025 | $292.5M | 53.9% | $-40.0M | $-34.0M | $-0.83 | — |
| Q3 2025 | $72.0M | 54.0% | $-10.0M | $-4.4M | $-0.11 | — |
| Q2 2025 | $72.8M | 54.8% | $-11.1M | $-10.7M | $-0.26 | — |
| Q1 2025 | $67.5M | 54.4% | $-13.1M | $-12.8M | $-0.31 | — |
| Q4 2024 | $71.0M | 54.3% | $-14.4M | $-13.4M | $-0.33 | — |
| FY 2024 | $303.9M | 50.9% | $-192.4M | $-184.3M | $-4.59 | — |
| Q3 2024 | $75.2M | 47.7% | $-199.9M | $-187.7M | $-4.67 | — |
| Q2 2024 | $79.1M | 50.9% | $-13.1M | $-29.0M | $-0.72 | — |